Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy.

DeFilipp Z, Advani AS, Bachanova V, Cassaday RD, Deangelo DJ, Kebriaei P, Rowe JM, Seftel MD, Stock W, Tallman MS, Fanning S, Inamoto Y, Kansagra A, Johnston L, Nagler A, Sauter CS, Savani BN, Perales MA, Carpenter PA, Larson RA, Weisdorf D.

Biol Blood Marrow Transplant. 2019 Nov;25(11):2113-2123. doi: 10.1016/j.bbmt.2019.08.014. Epub 2019 Aug 22. Review.

PMID:
31446198
2.

Risks and Benefits of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Cancer: A Systematic Review and Meta-Analysis.

Grigor EJM, Fergusson D, Kekre N, Montroy J, Atkins H, Seftel MD, Daugaard M, Presseau J, Thavorn K, Hutton B, Holt RA, Lalu MM.

Transfus Med Rev. 2019 Apr;33(2):98-110. doi: 10.1016/j.tmrv.2019.01.005. Epub 2019 Feb 14.

3.

Recognizing subclinical hyposplenism.

Seftel MD.

CMAJ. 2019 Jan 7;191(1):E21. doi: 10.1503/cmaj.70852. No abstract available.

4.

Fludarabine, busulfan, and low-dose TBI conditioning versus cyclophosphamide and TBI in allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia.

Speziali C, Daly A, Abuhaleeqa M, Nitta J, Abou Mourad Y, Seftel MD, Paulson K.

Leuk Lymphoma. 2019 Mar;60(3):639-648. doi: 10.1080/10428194.2018.1493734. Epub 2018 Aug 30.

PMID:
30160568
5.

Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation.

Bhella S, Majhail NS, Betcher J, Costa LJ, Daly A, Dandoy CE, DeFilipp Z, Doan V, Gulbis A, Hicks L, Juckett M, Khera N, Krishnan A, Selby G, Shah NN, Stricherz M, Viswabandya A, Bredeson C, Seftel MD.

Biol Blood Marrow Transplant. 2018 May;24(5):909-913. doi: 10.1016/j.bbmt.2018.01.017. Epub 2018 Jan 31. Review.

6.

The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemia.

Grace RF, DeAngelo DJ, Stevenson KE, Neuberg D, Sallan SE, Mourad YRA, Bergeron J, Seftel MD, Kokulis C, Connors JM.

J Thromb Thrombolysis. 2018 Feb;45(2):306-314. doi: 10.1007/s11239-017-1597-7.

PMID:
29260426
7.

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.

Kebriaei P, Anasetti C, Zhang MJ, Wang HL, Aldoss I, de Lima M, Khoury HJ, Sandmaier BM, Horowitz MM, Artz A, Bejanyan N, Ciurea S, Lazarus HM, Gale RP, Litzow M, Bredeson C, Seftel MD, Pulsipher MA, Boelens JJ, Alvarnas J, Champlin R, Forman S, Pullarkat V, Weisdorf D, Marks DI; Acute Leukemia Committee of the CIBMTR.

Biol Blood Marrow Transplant. 2018 Apr;24(4):726-733. doi: 10.1016/j.bbmt.2017.11.025. Epub 2017 Dec 25.

8.

Myeloablative versus Reduced-Intensity Conditioning in Patients with Myeloid Malignancies: A Propensity Score-Matched Analysis.

Sibai H, Falcone U, Deotare U, Michelis FV, Uhm J, Gupta V, Kuruvilla J, Lipton JH, Seftel MD, Messner HA, Kim DDH.

Biol Blood Marrow Transplant. 2016 Dec;22(12):2270-2275. doi: 10.1016/j.bbmt.2016.08.030. Epub 2016 Sep 3.

9.

The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group.

Seftel MD, Kuruvilla J, Kouroukis T, Banerji V, Fraser G, Crump M, Kumar R, Chalchal HI, Salim M, Laister RC, Crocker S, Gibson SB, Toguchi M, Lyons JF, Xu H, Powers J, Sederias J, Seymour L, Hay AE.

Leuk Lymphoma. 2017 Jun;58(6):1358-1365. doi: 10.1080/10428194.2016.1239259. Epub 2016 Oct 17.

PMID:
27750483
10.

A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma.

Han M, Murugesan A, Bahlis NJ, Song K, White D, Chen C, Seftel MD, Howsen-Jan K, Reece D, Stewart K, Xie Y, Hay AE, Shepherd L, Djurfeldt M, Zhu L, Meyer RM, Chen BE, Reiman T.

Blood. 2016 Aug 4;128(5):732-5. doi: 10.1182/blood-2016-06-716902. Epub 2016 Jun 23. No abstract available.

PMID:
27338095
11.

Extracorporeal photopheresis in solid organ transplant-associated acute graft-versus-host disease.

Houston BL, Yan M, Tinckam K, Kamel-Reid S, Chang H, Kuo KH, Tsien C, Seftel MD, Avitzur Y, Grant D, Cserti-Gazdewich CM.

Transfusion. 2016 Apr;56(4):962-9. doi: 10.1111/trf.13467. Epub 2016 Feb 18.

PMID:
26892365
12.

A phase I study of elesclomol sodium in patients with acute myeloid leukemia.

Hedley D, Shamas-Din A, Chow S, Sanfelice D, Schuh AC, Brandwein JM, Seftel MD, Gupta V, Yee KW, Schimmer AD.

Leuk Lymphoma. 2016 Oct;57(10):2437-40. doi: 10.3109/10428194.2016.1138293. Epub 2016 Feb 5. No abstract available.

PMID:
26732437
13.

The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis.

Williams KM, Ahn KW, Chen M, Aljurf MD, Agwu AL, Chen AR, Walsh TJ, Szabolcs P, Boeckh MJ, Auletta JJ, Lindemans CA, Zanis-Neto J, Malvezzi M, Lister J, de Toledo Codina JS, Sackey K, Chakrabarty JL, Ljungman P, Wingard JR, Seftel MD, Seo S, Hale GA, Wirk B, Smith MS, Savani BN, Lazarus HM, Marks DI, Ustun C, Abdel-Azim H, Dvorak CC, Szer J, Storek J, Yong A, Riches MR.

Bone Marrow Transplant. 2016 Apr;51(4):573-80. doi: 10.1038/bmt.2015.316. Epub 2016 Jan 4.

14.

Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission.

Seftel MD, Neuberg D, Zhang MJ, Wang HL, Ballen KK, Bergeron J, Couban S, Freytes CO, Hamadani M, Kharfan-Dabaja MA, Lazarus HM, Nishihori T, Paulson K, Saber W, Sallan SE, Soiffer R, Tallman MS, Woolfrey AE, DeAngelo DJ, Weisdorf DJ; Acute Leukemia Committee of the CIBMTR and the Dana Farber ALL Consortium.

Am J Hematol. 2016 Mar;91(3):322-9. doi: 10.1002/ajh.24285.

15.

Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers.

Anthias C, Shaw BE, Kiefer DM, Liesveld JL, Yared J, Kamble RT, D'Souza A, Hematti P, Seftel MD, Norkin M, DeFilipp Z, Kasow KA, Abidi MH, Savani BN, Shah NN, Anderlini P, Diaz MA, Malone AK, Halter JP, Lazarus HM, Logan BR, Switzer GE, Pulsipher MA, Confer DL, O'Donnell PV.

Biol Blood Marrow Transplant. 2016 Mar;22(3):520-7. doi: 10.1016/j.bbmt.2015.11.008. Epub 2015 Nov 18.

16.

Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2.

Michelis FV, Messner HA, Atenafu EG, McGillis L, Lambie A, Uhm J, Alam N, Seftel MD, Gupta V, Kuruvilla J, Lipton JH, Kim DD.

Bone Marrow Transplant. 2015 Nov;50(11):1405-10. doi: 10.1038/bmt.2015.165. Epub 2015 Jul 13.

PMID:
26168067
17.

Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission.

Michelis FV, Atenafu EG, Gupta V, Kim DD, Kuruvilla J, Lipton JH, Loach D, Seftel MD, Uhm J, Alam N, Lambie A, McGillis L, Messner HA.

Bone Marrow Transplant. 2015 Jul;50(7):907-13. doi: 10.1038/bmt.2015.59. Epub 2015 Mar 30.

PMID:
25822226
18.

Modified EBMT Pretransplant Risk Score Can Identify Favorable-risk Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for AML, Not Identified by the HCT-CI Score.

Michelis FV, Messner HA, Uhm J, Alam N, Lambie A, McGillis L, Seftel MD, Gupta V, Kuruvilla J, Lipton JH, Kim DD.

Clin Lymphoma Myeloma Leuk. 2015 May;15(5):e73-81. doi: 10.1016/j.clml.2014.09.014. Epub 2014 Oct 5.

PMID:
25458081
19.

A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adults.

Seftel MD, Barnett MJ, Couban S, Leber B, Storring J, Assaily W, Fuerth B, Christofides A, Schuh AC.

Curr Oncol. 2014 Oct;21(5):234-50. doi: 10.3747/co.21.2183.

20.

Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia.

DeAngelo DJ, Stevenson KE, Dahlberg SE, Silverman LB, Couban S, Supko JG, Amrein PC, Ballen KK, Seftel MD, Turner AR, Leber B, Howson-Jan K, Kelly K, Cohen S, Matthews JH, Savoie L, Wadleigh M, Sirulnik LA, Galinsky I, Neuberg DS, Sallan SE, Stone RM.

Leukemia. 2015 Mar;29(3):526-34. doi: 10.1038/leu.2014.229. Epub 2014 Jul 31.

21.

Outcomes of human leukocyte antigen-matched sibling donor hematopoietic cell transplantation in chronic lymphocytic leukemia: myeloablative versus reduced-intensity conditioning regimens.

Sobecks RM, Leis JF, Gale RP, Ahn KW, Zhu X, Sabloff M, de Lima M, Brown JR, Inamoto Y, Hale GA, Aljurf MD, Kamble RT, Hsu JW, Pavletic SZ, Wirk B, Seftel MD, Lewis ID, Alyea EP, Cortes J, Kalaycio ME, Maziarz RT, Saber W.

Biol Blood Marrow Transplant. 2014 Sep;20(9):1390-8. doi: 10.1016/j.bbmt.2014.05.020. Epub 2014 May 28.

22.

Acute promyelocytic leukaemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukaemia referral centres: a pan-Canadian epidemiological study.

Paulson K, Serebrin A, Lambert P, Bergeron J, Everett J, Kew A, Jones D, Mahmud S, Meloche C, Sabloff M, Sharif I, Storring J, Turner D, Seftel MD.

Br J Haematol. 2014 Sep;166(5):660-6. doi: 10.1111/bjh.12931. Epub 2014 Apr 30.

PMID:
24780059
23.

Early lymphocyte recovery at 28 d post-transplant is predictive of reduced risk of relapse in patients with acute myeloid leukemia transplanted with peripheral blood stem cell grafts.

Michelis FV, Messner HA, Loach D, Uhm J, Gupta V, Lipton JH, Seftel MD, Kuruvilla J, Kim DD.

Eur J Haematol. 2014 Oct;93(4):273-80. doi: 10.1111/ejh.12338. Epub 2014 Apr 29.

PMID:
24725056
25.

The role of hematopoietic cell transplantation in adult ALL: clinical equipoise persists.

Paulson K, Szwajcer D, Raymond CB, Seftel MD.

Leuk Res. 2014 Feb;38(2):176-9. doi: 10.1016/j.leukres.2013.10.021. Epub 2013 Nov 1.

PMID:
24314630
26.

Increased risk of second malignancies in chronic lymphocytic leukaemia patients as compared with follicular lymphoma patients: a Canadian population-based study.

Beiggi S, Johnston JB, Seftel MD, Pitz MW, Kumar R, Banerji V, Griffith EJ, Gibson SB.

Br J Cancer. 2013 Sep 3;109(5):1287-90. doi: 10.1038/bjc.2013.381. Epub 2013 Jul 16.

27.

Publication bias is present in blood and marrow transplantation: an analysis of abstracts at an international meeting.

Paulson K, Saeed M, Mills J, Cuvelier GD, Kumar R, Raymond C, Robinson T, Szwajcer D, Wall D, Seftel MD.

Blood. 2011 Dec 15;118(25):6698-701. doi: 10.1182/blood-2011-08-367466. Epub 2011 Oct 28.

PMID:
22039259
28.

Unintended benefit of anabolic steroid use in hemophilia B leiden.

Rimmer EK, Seftel MD, Israels SJ, Houston DS.

Am J Hematol. 2012 Jan;87(1):122-3. doi: 10.1002/ajh.22190. Epub 2011 Oct 31. No abstract available.

29.

Inversion and deletion of 16q22 defined by array CGH, FISH, and RT-PCR in a patient with AML.

Dawson AJ, Bal S, McTavish B, Tomiuk M, Schroedter I, Ahsanuddin AN, Seftel MD, Vallente R, Mai S, Cotter PD, Hovanes K, Gorre M, Gunn SR.

Cancer Genet. 2011 Jun;204(6):344-7. doi: 10.1016/j.cancergen.2011.05.005.

PMID:
21763633
30.

Monomorphic ventricular tachycardia caused by arsenic trioxide therapy for acute promyelocytic leukaemia.

Ducas RA, Seftel MD, Ducas J, Seifer C.

J R Coll Physicians Edinb. 2011 Jun;41(2):117-8. doi: 10.4997/JRCPE.2011.204.

PMID:
21677914
31.

Dose of vitamin K in emergency reversal of warfarin anticoagulation.

Seftel MD.

CMAJ. 2011 Feb 22;183(3):349. doi: 10.1503/cmaj.111-2011. No abstract available.

32.

The role of allogeneic stem cell transplantation for adult acute lymphoblastic leukemia.

Paulson K, Szwajcer D, Seftel MD.

Transfus Apher Sci. 2011 Apr;44(2):197-203. doi: 10.1016/j.transci.2011.01.016. Epub 2011 Feb 16. Review.

PMID:
21330213
33.

Long-term follow-up of patients undergoing auto-SCT for advanced germ cell tumour: a multicentre cohort study.

Seftel MD, Paulson K, Doocey R, Song K, Czaykowski P, Coppin C, Forrest D, Hogge D, Kollmansberger C, Smith CA, Shepherd JD, Toze CL, Murray N, Sutherland H, Nantel S, Nevill TJ, Barnett MJ.

Bone Marrow Transplant. 2011 Jun;46(6):852-7. doi: 10.1038/bmt.2010.250. Epub 2010 Nov 1.

PMID:
21042312
34.

Azacytidine as a novel agent in the treatment of acute lymphoblastic leukemia.

Paulson K, Kumar R, Ahsanuddin A, Seftel MD.

Leuk Lymphoma. 2011 Jan;52(1):134-6. doi: 10.3109/10428194.2010.512965. Epub 2010 Sep 21. No abstract available.

PMID:
20858102
35.

Kikuchi-Fujimoto disease: lymphadenopathy in siblings.

Stasiuk A, Teschke S, Williams GJ, Seftel MD.

CMAJ. 2011 Jan 11;183(1):E58-60. doi: 10.1503/cmaj.091347. Epub 2010 Sep 7. No abstract available.

36.

Total body irradiation compared with BEAM: Long-term outcomes of peripheral blood autologous stem cell transplantation for non-Hodgkin's lymphoma.

Liu HW, Seftel MD, Rubinger M, Szwajcer D, Demers A, Nugent Z, Schroeder G, Butler JB, Cooke A.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):513-20. doi: 10.1016/j.ijrobp.2009.08.024. Epub 2010 Feb 4.

PMID:
20137862
37.

Controversies in the management of fever in the neutropenic cancer patient.

Seftel MD.

Transfus Apher Sci. 2010 Apr;42(2):151-6. doi: 10.1016/j.transci.2010.01.011. Epub 2010 Jan 27.

PMID:
20106722
38.

Does location matter? Rural vs urban outcomes after blood and marrow transplantation in a population-based Canadian cohort.

Paulson K, Lambert P, Bredeson C, Demers A, Nowatzki J, Richardson E, Rubinger M, Szwajcer D, Seftel MD.

Bone Marrow Transplant. 2010 Jul;45(7):1167-73. doi: 10.1038/bmt.2009.332. Epub 2009 Dec 14.

PMID:
20010868
39.

High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: a population-based Canadian cohort.

Seftel MD, Demers AA, Banerji V, Gibson SB, Morales C, Musto G, Pitz MW, Johnston JB.

Leuk Res. 2009 Nov;33(11):1463-8. doi: 10.1016/j.leukres.2009.06.013. Epub 2009 Jul 5.

PMID:
19581000
40.

Performance status, but not the hematopoietic cell transplantation comorbidity index (HCT-CI), predicts mortality at a Canadian transplant center.

Guilfoyle R, Demers A, Bredeson C, Richardson E, Rubinger M, Szwajcer D, Seftel MD.

Bone Marrow Transplant. 2009 Jan;43(2):133-9. doi: 10.1038/bmt.2008.300. Epub 2008 Sep 1.

PMID:
18762762
41.

The role of hematopoietic stem cell transplantation in Chronic Lymphocytic Leukemia.

Banerji V, Johnston JB, Seftel MD.

Transfus Apher Sci. 2007 Aug;37(1):57-62. Epub 2007 Oct 4. Review.

PMID:
17919979
42.

High rate of discordance between clinical and autopsy diagnoses in blood and marrow transplantation.

Seftel MD, Ho M, Pruthi D, Orbanski S, Rubinger M, Schacter B, Szwajcer D, Bredeson C, Demers AA.

Bone Marrow Transplant. 2007 Dec;40(11):1049-53. Epub 2007 Sep 17.

PMID:
17873915
43.

Type I Gaucher disease following chemotherapy for light chain multiple myeloma.

Cheung WY, Greenberg CR, Bernstein K, Schacter B, Fourie T, Seftel MD.

Intern Med. 2007;46(15):1255-8. Epub 2007 Aug 2.

44.

Myeloid sarcoma of the uterus presenting as vaginal bleeding.

Pitz MW, Maslyak O, Morales C, Seftel MD.

Intern Med J. 2006 Oct;36(10):669-71.

PMID:
16958646
45.

Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia.

Greenwood MJ, Seftel MD, Richardson C, Barbaric D, Barnett MJ, Bruyere H, Forrest DL, Horsman DE, Smith C, Song K, Sutherland HJ, Toze CL, Nevill TJ, Nantel SH, Hogge DE.

Leuk Lymphoma. 2006 Jul;47(7):1245-52.

PMID:
16923553
46.

Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness.

Seftel MD, Growe GH, Petraszko T, Benny WB, Le A, Lee CY, Spinelli JJ, Sutherland HJ, Tsang P, Hogge DE.

Blood. 2004 Jan 1;103(1):333-9. Epub 2003 Sep 4.

PMID:
12958065
47.

Intra-cerebral relapse following prolonged remission after autologous stem cell transplantation for multiple myeloma.

Seftel MD, Maguire J, Voss N, Woodhurst WB, Dalal BI, Shepherd JD.

Leuk Lymphoma. 2002 Dec;43(12):2399-403.

PMID:
12613531
48.

Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22).

Seftel MD, Bruyere H, Copland M, Hogge DE, Horsman DE, Nantel SH, Shepherd JD, Lavoie JC, Le A, Sutherland HJ, Toze CL, Nevill TJ.

Eur J Haematol. 2002 Oct;69(4):193-9.

PMID:
12431237
49.

Treatment of lymphoid malignancies with non-myeloablative stem cell transplantation.

Seftel MD, Lavoie J, Barnett MJ, Conneally E.

Hematology. 2002 Jun;7(3):151-5. Review.

PMID:
12243977
50.

Hematopoietic stem cell transplantation: the Vancouver experience.

Seftel MD, Barnett MJ.

Hematology. 2002 Jun;7(3):145-9.

PMID:
12243976

Supplemental Content

Loading ...
Support Center